跳至主要内容
临床试验/CTRI/2019/04/018392
CTRI/2019/04/018392招募中不适用

Multi-center cross-sectional epidemiological study tocharacterize the prevalence and distribution oflipoprotein(a) levels among patients with establishedcardiovascular disease

Novartis Healthcare Pvt Ltd38 个研究点 分布在 1 个国家目标入组 45,000 人开始时间: 2019年4月30日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
45,000
试验地点
38
主要终点
To evaluate the prevalence of normal and elevated Lp(a) levels in patients with established

研究概览

简要总结

This is a Multi-center cross-sectional epidemiological study to characterize the prevalence and distribution of lipoprotein(a) levels among patients with established cardiovascular disease. The purpose of this study is to To evaluate the prevalence of normal and elevated Lp(a) levels in patients with established CVD.

Target FPFV for India is 30-April-2019.

Sample size for India: 3250

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Signed informed consent must be obtained prior to participation in the study
  • Male and female ≥ 18 to ≤ 80 years of age
  • Established CVD defined as one of the following: -History of a myocardial infarction (MI) ≥3 months and ≤10 years before the study visit -History of ischemic stroke ≥ 3 months and ≤ 10 years before the study visit -Symptomatic PAD (intermitted claudication with ankle-brachial index.

排除标准

  • 未提供

结局指标

主要结局

To evaluate the prevalence of normal and elevated Lp(a) levels in patients with established

时间窗: One Day

CVD

时间窗: One Day

次要结局

  • -To evaluate the median and other relevant(statistics describing the distribution of Lp(a) within)

研究者

发起方
Novartis Healthcare Pvt Ltd
申办方类型
Pharmaceutical industry-Global

研究点 (38)

Loading locations...

相似试验